Closing Heart Pouch in Dialysis Patients with Atrial Fibrillation
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing a minimally invasive procedure to close off a part of the heart (the left atrial appendage) in people with kidney failure on dialysis who also have atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have end-stage kidney failure and are on dialysis (peritoneal or hemodialysis)
- You have been diagnosed with atrial fibrillation (a type of irregular heart rhythm that is not caused by a heart valve problem)
- Your stroke risk score (CHA2DS2-VASc) is 2 or higher
- You can take blood thinners and other required medications after the procedure, and attend follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure that seals off the left atrial appendage (a small heart pouch) to help prevent stroke in people with atrial fibrillation. You may be considered if your stroke risk is high and you are already on blood-thinner medicine.
This trial looks at the best blood-thinning (antiplatelet) plan after a left atrial appendage closure procedure in people with kidney failure on dialysis. It may help reduce stroke risk while also lowering medicine-related side effects.
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
This study tests whether closing a heart pouch called the left atrial appendage can prevent future strokes in people with atrial fibrillation who had an ischemic stroke even while taking blood thinners. It may help reduce stroke risk by blocking a common place where clotting can start.
This study looks at a part of the heart called the left atrial appendage during open-heart surgery. It aims to learn more about heart rhythm problems and blood clots, which may help improve future treatments.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
Hear when a new Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.